United States - English - NLM (National Library of Medicine)

ucsf radiopharmaceutical facility - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c-11 33.1 mci in 1 ml - choline c 11 injection is indicated for positron emission tomography (pet) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (ct) or magnetic resonance imaging (mri). in these patients, 11 c-choline pet imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. suspected prostate recurrence is based upon elevated blood prostate specific antigen (psa) levels following initial therapy. in clinical studies, images were produced with pet/ct coregistration. limitation of u se: 11 c-choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer. none. pregnancy category c. there are no adequate and well controlled studies with choline c 11 injection in pregnant women and the fetal radiation dose from a 11 c-choline pet imaging study is unknown.  it is not known whether choline c 11 injection can cause fetal harm when administered to a pregnant w

United States - English - NLM (National Library of Medicine)

methapharm inc. - methacholine chloride (unii: 0w5etf9m2k) (methacholine - unii:03v657zd3v) - methacholine 100 mg in 100 mg - provocholine, used in a methacholine challenge test, is indicated for the diagnosis of bronchial airway hyperreactivity in adults and pediatric patients five years of age and older who do not have clinically apparent asthma. provocholine is contraindicated in the following: - hypersensitivity to methacholine or other parasympathomimetic agents. reactions have included rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. - baseline fev1 < 60% predicted (adults or pediatric patients) or <1.5 l (adults) risk summary the available data from published literature on provocholine use in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies evaluating effects of methacholine chloride on embryofetal development have not been conducted. diagnosis of bronchial airway hyperreactivity with bronchoprovocation challenge is not recommended for pregnant wo

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

g.r. lane health products ltd - glycerol; choline salicylate - ear drops - 126.2mg/1ml ; 160mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - choline salicylate, quantity: 87 mg/g - gel - excipient ingredients: propyl hydroxybenzoate; methylcellulose; menthol; cetalkonium chloride; glycerol; ethanol; methyl hydroxybenzoate; propylene glycol; butylated hydroxyanisole; star anise oil; purified water - oral pain relief for mouth ulcers and sores. relieves pain and discomfort associated with mouth ulcers, sores and babies teething ailments. useful in relieving pain and discomfort of new dentures.

Australia - English - Department of Health (Therapeutic Goods Administration)

nova pharmaceuticals australasia pty ltd - choline salicylate, quantity: 87 mg - gel - excipient ingredients: star anise oil; sodium hydroxide; cetalkonium chloride; saccharin sodium; carbomer 940; purified water; glycerol; menthol - provides soothing relief from the pain and discomfort associated with infant teething disorders, mouth ulcers and sores, and new dentures.

Ireland - English - HPRA (Health Products Regulatory Authority)

ssl international plc - choline salicylate glycerol - ear drops solution - 20/12.6 %w/v

United States - English - NLM (National Library of Medicine)

lannett company, inc. - choline magnesium trisalicylate (unii: djj95fjp1h) (salicylic acid - unii:o414pz4lpz) - salicylic acid 500 mg in 5 ml - osteoarthritis, rheumatoid arthritis and acute painful shoulder : salicylates are considered the base therapy of choice in the arthritides; and choline magnesium trisalicylate preparation is indicated for the relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and other arthritides. choline magnesium trisalicylate liquid is indicated in the long-term management of these diseases and especially in the acute flare of rheumatoid arthritis. choline magnesium trisalicylate liquid is also indicated for the treatment of acute painful shoulder. choline magnesium trisalicylate liquid is effective and generally well tolerated, and is logical choice whenever salicylate treatment is indicated. it is particularly suitable when a once-a-day or b.i.d. dosage regimen is important to patient compliance; when gastrointestinal intolerance to aspirin is encountered; when gastrointestinal microbleeding or hematologic effects of aspirin are considered a patient hazard; and when interference (or the risk of int

New Zealand - English - Medsafe (Medicines Safety Authority)

medicon industries ltd (gone - no products on market) - choline salicylate; glycerol - ear drops - active: choline salicylate glycerol

United States - English - NLM (National Library of Medicine)

the university of texas md anderson cancer center - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c-11 33.1 mci in 1 ml

United States - English - NLM (National Library of Medicine)

precision nuclear llc - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c-11 33.1 mci in 1 ml